Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis

Table 1 Demographic and baseline characteristics of the patients (n = 30)

Characteristics
Sex—No. of patients (%)
Male	18.0	(60.0)
Female	12.0	(40.0)
Age (years)1	48.8	(13.6)
Weight (kg)1	55.9	(11.1)
TSAT (%)2	39.6	(23.0)
Ferritin (ng/mL)2	931.2	(592.7)
Hemoglobin (g/dL)1	7.4	(1.3)
Hematocrit (%)1	22.2	(4.0)
Reticulocyte count (%)1	1.1	(0.9)
eGFR (ml/min/1.73 m2	6.2	(3.3)
BUN (mg%)2	77.1	(34.2)
Creatinine (mg%)2	10.0	(4.5)
Albumin (g%)2	3.8	(0.6)
Vitamin B12 (pg/mL)2,4	922.3	(422.9)
Folic acid (ng/mL)2,4
RBC folate (n = 19)	8192.8	(4785.0)
Serum folate (n = 10)	102.2	(217.4)
C-reactive protein (mg/L)2	10.7	(29.5)

All data were presented as mean (standard deviation), unless otherwise stated.

¹Data from screening visit.

²Data from Week 0 prior to study drug initiation.

³Data were calculated using chronic kidney disease epidemiology collaboration formula[13].

⁴Data available in 29 patients. BUN: Blood urea nitrogen; eGFR: Estimated glomerular filtration rate; RBC: Red blood cell; TSAT: Transferrin saturation.